The profile is currenly unclaimed by the seller. All information is provided by CB Insights.

Stage

Unattributed VC | Alive

Total Raised

$16.75M

Last Raised

$750K | 20 yrs ago

About ProdiGene

ProdiGene is a Healthcare/Biotechnology company based in College Station, Texas. ProdiGene has received investment from Cybus Capital Advisors.

ProdiGene Headquarter Location

101 Gateway Boulevard Suite 100

College Station, Texas, 77845,

United States

979-690-8537

Predict your next investment

The CB Insights tech market intelligence platform analyzes millions of data points on venture capital, startups, patents , partnerships and news mentions to help you see tomorrow's opportunities, today.

ProdiGene Patents

ProdiGene has filed 5 patents.

patents chart

Application Date

Grant Date

Title

Related Topics

Status

3/14/2012

4/1/2014

Vaccines, Vaccination, Molecular biology, Opioid peptides, Plant physiology

Grant

Application Date

3/14/2012

Grant Date

4/1/2014

Title

Related Topics

Vaccines, Vaccination, Molecular biology, Opioid peptides, Plant physiology

Status

Grant

Latest ProdiGene News

Special Report: Corntamination — Edible GMO Hepatitis B Vaccines Coming Soon!

Aug 26, 2014

“Just one mistake by a biotech company, we’ll be eating other people’s prescription drugs in our cornflakes.” — Larry Bohlen, Health and Environment Programs Director at Friends of the Earth Do you remember the biotech firm Prodigene? In a special investigative report, we followed the trail of biopharming, where science is using genetically engineered crops to grow pharmaceutical and vaccine components. Some of these treatments are developed to be eaten directly as food. One firm, Prodigene, was caught in a major scandal back in 2002 after experimental pharmaceuticals growing in open air field trials – such as AIDS and Hepatitis B vaccines, and treatments for gastrointestinal diseases – contaminated nearby food crops. Rather than reign in their potentially hazardous test crops, the USDA – publicly supportive of biopharmaceutical potential – actually helped Prodigene pay back damages with an interest-free loan and then went on to cover further research. However, the firm disappeared after a subsequent contamination violation led to a USDA decision barring them and their principals from receiving any future testing permits. But did Prodigene really stop its pharma-crop production? Melissa Melton followed its founder and lead research scientist through his work at a spinoff firm, where human trials are set to begin soon for a Hepatitis B vaccine grown in genetically modified corn.

  • Where is ProdiGene's headquarters?

    ProdiGene's headquarters is located at 101 Gateway Boulevard, College Station.

  • What is ProdiGene's latest funding round?

    ProdiGene's latest funding round is Unattributed VC.

  • How much did ProdiGene raise?

    ProdiGene raised a total of $16.75M.

  • Who are the investors of ProdiGene?

    Investors of ProdiGene include Cybus Capital Advisors.

Discover the right solution for your team

The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution.

Request a demo

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.